Remus and its group of companies specialize in marketing pharmaceutical products with expertise in Critical Care, Neurology, Cardiology, and Diabetic categories, and recently getting off-patent molecules in various dosage forms.
We believe in creating
a positive difference
in people’s lives.
Acknowledged and trusted by patients
and medical professionals
All of this and more reflects the growth and success of Remus Pharmaceuticals
1000
Group Company Employees
150
Million dollars in group revenue for fiscal year 2023
900
CTD dossier
50
Countries
150
Active customers
500
Total registrations
10
USFDA approved products